HCWB
HCW Biologics Inc
NASDAQ: HCWB · HEALTHCARE · BIOTECHNOLOGY
$0.47
+15.63% today
Updated 2026-04-30
Market cap
$2.53M
P/E ratio
—
P/S ratio
54.51x
EPS (TTM)
$-10.63
Dividend yield
—
52W range
$0 – $11
Volume
10.9M
HCW Biologics Inc (HCWB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-6.77M | $-10.43M | $-10.98M | $-10.39M | $-22.51M | $-14.23M | $-13.39M |
| Capital expenditures | $1.46M | $186682.00 | $47263.00 | $10.28M | $6.20M | $261617.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $1763.00 | $21875.00 | $360975.00 | $1.12M | $1.00M | $1.01M | $768623.00 |
| Free cash flow | $-8.23M | $-10.62M | $-11.02M | $-20.66M | $-28.72M | $-14.49M | $-13.39M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | $2.82M | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $10.60M | — | — | — |